Scientists Identify Gene Variation Linked With An Increased Risk Of Alzheimer's Disease

Scientists, for the first time, have found that the variation in a gene, responsible for the production of a protein called neuroglobin, is linked with an increased risk of Alzheimer's Disease (AD).

For the study, researchers at the McKusick-Nathans Institute of Genetic Medicine of the Johns Hopkins University School of Medicine analysed the genetic neighbourhood of neuroglobin.

Medicines Meant to Treat Alzheimers Found to be Good for Victims of Dementia
Cholinesterase inhibitors, that help victims of Alzheimer's disease can also assist in the management of behavioural and psychological symptoms of dementia, a new study has shown.

The team found that individuals with genetic variations linked with less neuroglobin production had an increased risk for AD.

"An intriguing part of this study was the high levels of neuroglobin that we found in the Alzheimer's brain, which was exactly the opposite from what we expected," said Dr. Dimitrios Avramopoulos, an associate professor in Hopkins' Institute of Genetic Medicine and the Department of Psychiatry.

The researchers measured levels of gene product in 56 different samples of human brain tissue-30 from confirmed cases of Alzheimer's and 26 without brain disease.

Early Alzheimers in Drivers may Prove Potentially Dangerous
Researchers at Rhode Island Hospital and Brown University have revealed that people with early Alzheimer’s Disease (AD) are more prone to accidents as well as performing poorly in road tests

They found that neuroglobin levels decreased with advancing age, which was consistent with risk of Alzheimer's increasing with advancing age.

They also observed that levels of neuroglobin were lower in women than in men, suggesting that women had a slightly higher risk of Alzheimer's.

Pain Killers Do Not Prevent Alzheimer's: Study
Anti-inflammatory pain relievers such as Ibupofren (Advil, Motril) and naproxen (Aleve) may delay the onset of Alzheimer's but do not prevent it, according to a new medical study.

And, surprisingly, neuroglobin levels were higher in the brain tissue from Alzheimer's patients than that of the control group.

Earlier studies highlighted a protective function for neuroglobin and showed that mouse brains respond to stress, which in this case is a lack of oxygen, by producing more neuroglobin.

Avramopoulos explained: "The older we get, the less neuroglobin this particular gene produces in our brains, unless something stimulates the gene to produce more. That something could be a stressor such as a lack of oxygen resulting from stoke or emphysema, for instance. And it looks like it also could be Alzheimer's disease. Further work on this gene will likely provide intervention targets for a multitude of very common conditions including Alzheimer's."

The study has been published in Neurobiology of Aging.

Source-ANI
ARU